Business Description
Morphic Holding Inc
NAICS : 325412
SIC : 2834
ISIN : US61775R1059
Description
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 300.49 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 32.2 | |||||
| Beneish M-Score | -32.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -79.9 | |||||
| 3-Year EBITDA Growth Rate | -40.7 | |||||
| 3-Year EPS without NRI Growth Rate | -34.7 | |||||
| 3-Year FCF Growth Rate | -20.8 | |||||
| 3-Year Book Growth Rate | 45.7 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.75 | |||||
| 9-Day RSI | 41.28 | |||||
| 14-Day RSI | 40.12 | |||||
| 6-1 Month Momentum % | 64.32 | |||||
| 12-1 Month Momentum % | -21.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 28.94 | |||||
| Quick Ratio | 28.94 | |||||
| Cash Ratio | 28.43 | |||||
| Days Sales Outstanding | 379.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.8 | |||||
| Shareholder Yield % | -31.9 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -34296.74 | |||||
| Net Margin % | -29192.9 | |||||
| FCF Margin % | -21643.12 | |||||
| ROE % | -26 | |||||
| ROA % | -25.14 | |||||
| ROIC % | -2293.22 | |||||
| ROC (Joel Greenblatt) % | -3126.94 | |||||
| ROCE % | -30.46 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2130 | |||||
| PB Ratio | 1.98 | |||||
| Price-to-Tangible-Book | 1.98 | |||||
| EV-to-EBIT | -3.83 | |||||
| EV-to-EBITDA | -3.85 | |||||
| EV-to-Revenue | 1311.95 | |||||
| EV-to-Forward-Revenue | 683.53 | |||||
| EV-to-FCF | -6.02 | |||||
| Price-to-Net-Current-Asset-Value | 1.99 | |||||
| Price-to-Net-Cash | 2.03 | |||||
| Earnings Yield (Greenblatt) % | -26.11 | |||||
| FCF Yield % | -8.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Morphic Holding Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.487 | ||
| EPS (TTM) (€) | -3.236 | ||
| Beta | 1 | ||
| Volatility % | 79.65 | ||
| 14-Day RSI | 40.12 | ||
| 14-Day ATR (€) | 0.767687 | ||
| 20-Day SMA (€) | 27.65 | ||
| 12-1 Month Momentum % | -21.65 | ||
| 52-Week Range (€) | 18.5 - 56.5 | ||
| Shares Outstanding (Mil) | 50.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Morphic Holding Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Morphic Holding Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Morphic Holding Inc Frequently Asked Questions
What is Morphic Holding Inc(FRA:31Y)'s stock price today?
The current price of FRA:31Y is €26.40. The 52 week high of FRA:31Y is €56.50 and 52 week low is €18.50.
When is next earnings date of Morphic Holding Inc(FRA:31Y)?
The next earnings date of Morphic Holding Inc(FRA:31Y) is 2024-04-25 Est..
Does Morphic Holding Inc(FRA:31Y) pay dividends? If so, how much?
Morphic Holding Inc(FRA:31Y) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers